Information  X 
Enter a valid email address

Mereo BioPharma Grp (MPH)

  Print   

Friday 06 March, 2020

Mereo BioPharma Grp

Block listing Interim Review

RNS Number : 1953F
Mereo BioPharma Group plc
06 March 2020
 

Mereo BioPharma Group plc

 

Block Listing Interim Review

 

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies, Mereo BioPharma Group plc makes the following update on its block listing:

 

Date: 6 March 2020

 

Name of applicant:

Mereo BioPharma Group plc

Name of scheme:

2015 Plan

Mereo BioPharma Group plc Share Option Plan

Period of return:

From:

06/09/19

To:

06/03/20

Balance of unallotted securities under scheme(s) from previous return:

7,565,929

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

7,565,929

 

Name of contact:

Charles Sermon

Telephone number of contact:

+44 (0)333 023 7300

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRKZGGFKKNGGZM

a d v e r t i s e m e n t